C07D 471/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in
Official title: Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
C07D471/00 (Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in) appears on 23,028 US grants and 28,001 published applications in this corpus.
Search patents in C07D- Granted patents
- 23,028
- Published applications
- 28,001
- Assignees
- 5,449
- Inventors
- 49,169
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 121 | 0 |
| 1977 | 97 | 0 |
| 1978 | 101 | 0 |
| 1979 | 56 | 0 |
| 1980 | 96 | 0 |
| 1981 | 104 | 0 |
| 1982 | 92 | 0 |
| 1983 | 65 | 0 |
| 1984 | 98 | 0 |
| 1985 | 116 | 0 |
| 1986 | 136 | 0 |
| 1987 | 134 | 0 |
| 1988 | 162 | 0 |
| 1989 | 169 | 0 |
| 1990 | 194 | 0 |
| 1991 | 218 | 0 |
| 1992 | 215 | 0 |
| 1993 | 235 | 0 |
| 1994 | 201 | 0 |
| 1995 | 229 | 0 |
| 1996 | 279 | 0 |
| 1997 | 352 | 0 |
| 1998 | 281 | 0 |
| 1999 | 258 | 0 |
| 2000 | 254 | 0 |
| 2001 | 306 | 71 |
| 2002 | 323 | 390 |
| 2003 | 391 | 581 |
| 2004 | 330 | 898 |
| 2005 | 353 | 768 |
| 2006 | 404 | 745 |
| 2007 | 419 | 835 |
| 2008 | 421 | 841 |
| 2009 | 537 | 994 |
| 2010 | 599 | 1134 |
| 2011 | 593 | 1100 |
| 2012 | 767 | 1025 |
| 2013 | 984 | 1079 |
| 2014 | 992 | 1261 |
| 2015 | 1126 | 1272 |
| 2016 | 977 | 1333 |
| 2017 | 1161 | 1229 |
| 2018 | 1048 | 1275 |
| 2019 | 1052 | 1349 |
| 2020 | 1024 | 1379 |
| 2021 | 939 | 1264 |
| 2022 | 798 | 1366 |
| 2023 | 763 | 1686 |
| 2024 | 874 | 1628 |
| 2025 | 962 | 1438 |
| 2026 | 622 | 1060 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Crystalline form of heterocyclic compound as protein kinase inhibitor6 Oct 2026US 12,753,174 B2Hk Inno. N Corporation
- FGFR inhibitor compound and use thereof6 Oct 2026US 12,753,179 B2Shenzhen Kangsu Pharmaceutical Technology Co., Ltd.
- Spirotricycle RIPK1 inhibitors and methods of uses thereof6 Oct 2026US 12,753,190 B2Merck Sharp & Dohme Corp.
- Organic light emitting diode and organic light emitting display device including the same6 Oct 2026US 12,757,570 B2LG Display Co., Ltd.
- Compounds for treating hereditary spastic paraplegia8 Oct 2026US 2026/0306465 A1Children's Medical Center Corporation
- Organic compounds8 Oct 2026US 2026/0306489 A1Intra-Cellular Therapies, Inc.
- Technologies targeting cell states8 Oct 2026US 2026/0306640 A1Auron Therapeutics, Inc.
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
Most cited
By later US patents
- 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use451US 4,689,338 ARiker Laboratories, Inc. · 1987
- P38 inhibitors and methods of use thereof444US 7,799,782 B2Array BioPharma Inc. · 2010
- 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines350US 5,389,640 AMinnesota Mining and Manufacturing Company · 1995
- Alkynylamino-nucleotides340US 5,047,519 AE. I. Du Pont de Nemours and Company · 1991
- Olefinic 1H-imidazo(4,5-c)quinolin-4-amines319US 4,929,624 AMinnesota Mining and Manufacturing Company · 1990